Skip to content

Multiclinical Study for Diabetic Macrovascular complications(MSDM)

Multiclinical Study for Diabetic Macrovascular complications(MSDM) - MSDM

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006244
Enrollment
900
Registered
2011-08-29
Start date
1990-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To clarify the clinical features of diabetic macroangiopathy in our country and to set up the control critelia for the multiple risk factors.

Interventions

None listed

Sponsors

MSDM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: type 2 diabetes with or without MA,who chan be followed periodically in out patient clinic.

Exclusion criteria

Exclusion criteria: those who can not visit clinic periodically or age above 80. Brain hemorrhage was removed from CVD.

Design outcomes

Primary

MeasureTime frame
Incidence and clinical features of MA and the relationship between MA and various riskfactors have been followed clinically in multiple facilities.

Secondary

MeasureTime frame
Relationship between MA and microvascular complications has been evaluated.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026